Literature DB >> 6215970

Adverse reaction to ipratropium bromide.

O M Jolobe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6215970      PMCID: PMC1500435          DOI: 10.1136/bmj.285.6352.1425-d

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  VARIATION OF DRUG ACTION ON AIRWAY OBSTRUCTION IN MAN.

Authors:  R E ALTOUNYAN
Journal:  Thorax       Date:  1964-09       Impact factor: 9.139

2.  The principles of drug action.

Authors:  W D PATON
Journal:  Proc R Soc Med       Date:  1960-10

3.  Atropine responsiveness in asthma in relation to steroid aerosol therapy.

Authors:  O M Jolobe; D J Lane
Journal:  Br J Dis Chest       Date:  1981-10

4.  Anticholinergic versus beta 2-adrenergic therapy in allergic airways obstruction: double-blind trials on bronchodilator effect and antiallergic protection of oxitropium bromide and fenoterol.

Authors:  G Schultze-Werninghaus
Journal:  Respiration       Date:  1981       Impact factor: 3.580

5.  Micropipette measurement of airway submucosal gland secretion: laryngeal reflex.

Authors:  V F German; I F Ueki; J A Nadel
Journal:  Am Rev Respir Dis       Date:  1980-09
  5 in total
  4 in total

1.  Adverse reactions to the non-drug constituents of nebuliser solutions.

Authors:  R Beasley; P Rafferty; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

2.  Bronchoconstriction induced by nebulised ipratropium bromide: relation to the bromide ion.

Authors:  P Rafferty; R Beasley; P H Howarth; J S Mann; S T Holgate
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-13

3.  Bronchoconstriction in response to ipratropium bromide.

Authors:  K R Patel; W M Tullett
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-23

4.  Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution.

Authors:  P Rafferty; R Beasley; S T Holgate
Journal:  Thorax       Date:  1988-06       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.